Wall Street analysts expect Aphria Inc (NYSE:APHA) to announce earnings per share (EPS) of ($0.05) for the current fiscal quarter, Zacks Investment Research reports. Two analysts have issued estimates for Aphria’s earnings. The lowest EPS estimate is ($0.07) and the highest is ($0.02). Aphria posted earnings of ($0.03) per share during the same quarter last year, which suggests a negative year-over-year growth rate of 66.7%. The firm is expected to issue its next quarterly earnings results on Wednesday, August 7th.
According to Zacks, analysts expect that Aphria will report full-year earnings of ($0.13) per share for the current financial year, with EPS estimates ranging from ($0.17) to ($0.05). For the next financial year, analysts anticipate that the firm will report earnings of ($0.03) per share, with EPS estimates ranging from ($0.17) to $0.23. Zacks Investment Research’s earnings per share calculations are a mean average based on a survey of analysts that follow Aphria.
Aphria (NYSE:APHA) last released its quarterly earnings results on Monday, April 15th. The company reported ($0.15) earnings per share (EPS) for the quarter, missing the Thomson Reuters’ consensus estimate of ($0.04) by ($0.11). The business had revenue of $55.24 million during the quarter, compared to analysts’ expectations of $41.11 million.
Several analysts have issued reports on APHA shares. Clarus Securities started coverage on Aphria in a research note on Tuesday, April 16th. They issued a “buy” rating and a $22.75 price target on the stock. Zacks Investment Research raised Aphria from a “strong sell” rating to a “hold” rating in a research note on Friday, May 10th. Jefferies Financial Group started coverage on Aphria in a research note on Friday, May 24th. They issued a “buy” rating and a $11.00 price target on the stock. Finally, ValuEngine raised Aphria from a “hold” rating to a “buy” rating in a research note on Monday, April 1st. Four equities research analysts have rated the stock with a hold rating and five have issued a buy rating to the company’s stock. The company has an average rating of “Buy” and an average target price of $14.75.
Large investors have recently added to or reduced their stakes in the stock. Advisory Services Network LLC raised its position in Aphria by 45.3% during the first quarter. Advisory Services Network LLC now owns 5,625 shares of the company’s stock valued at $52,000 after purchasing an additional 1,755 shares in the last quarter. Belpointe Asset Management LLC acquired a new position in Aphria during the first quarter valued at approximately $378,000. QCM Cayman Ltd. acquired a new position in Aphria during the first quarter valued at approximately $132,000. Actinver Wealth Management Inc. raised its position in Aphria by 168.7% during the first quarter. Actinver Wealth Management Inc. now owns 117,073 shares of the company’s stock valued at $1,092,000 after purchasing an additional 73,497 shares in the last quarter. Finally, B. Riley Financial Inc. acquired a new position in Aphria during the first quarter valued at approximately $311,000. 8.56% of the stock is currently owned by institutional investors and hedge funds.
APHA opened at $7.11 on Thursday. The firm has a 50-day moving average price of $6.92. Aphria has a 1 year low of $3.75 and a 1 year high of $16.86.
Aphria Company Profile
Aphria Inc produces and sells medical cannabis in Canada and internationally. The company offers sativa, indica, and hybrid medical marijuana products, as well as cannabis oils. It serves patients and health professionals. The company also sells its products online. Aphria Inc is headquartered in Leamington, Canada.
See Also: What are earnings reports?
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for Aphria Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Aphria and related companies with MarketBeat.com's FREE daily email newsletter.